Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | 0.00% | +9.79% | -22.46% |
09/05 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
06/05 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.46% | 21Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
+0.76% | 2.23TCr | |
-12.64% | 2.22TCr | |
-4.50% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+7.77% | 1.43TCr | |
+37.41% | 1.25TCr |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Baird Adjusts Price Target on bluebird bio to $7 From $10, Maintains Outperform Rating